Cocrystal Pharma Inc. (COCP)

CDI-988 Begins Phase 1a/b Clinical Trial


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
October 2, 2023
Report ID: 26128
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$1.46 3.7%
Market Cap
$14.9M
Price Target
Refer to Report
Volume
19.2K
52wk Range
$1.325 - $3.285
Related Research Reports
11/14/2023

3Q23 Reported As Three Trials Make Progress
3Q23 Reported As Three Trials Make Progress (COCP)
11/1/2023

Phase 2a Influenza Trial Receives Authorization To Begin
Phase 2a Influenza Trial Receives Authorization To Begin (COCP)
10/2/2023

CDI-988 Begins Phase 1a/b Clinical Trial
CDI-988 Begins Phase 1a/b Clinical Trial (COCP)
8/15/2023

2Q23 Reported With New Clinical Trials Ready To Begin
2Q23 Reported With New Clinical Trials Ready To Begin (COCP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.